SCHEMBL6265571

SCHEMBL6265571

CC(C)C[C@H](N)C(=O)N[C@H]([C]=O)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CTSC P53634 5/20 0.59
CTSL P07711 4/20 0.52
ANPEP P15144 1/20 0.51
RNPEP Q9H4A4 1/20 0.51
DNPEP Q9ULA0 1/20 0.51
CTSK P43235 2/20 0.51
LTA4H P09960 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CTSH P09668 1/20 0.51
CYP2D6 P10635 1/20 0.51
CTSS P25774 1/20 0.49
LARS1 Q9P2J5 1/20 0.49
MME P08473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8863955 1.00 CTSC (0.59) CTSCCTSLANPEPRNPEPDNPEP
SCHEMBL3497000 1.00 CTSC (0.59) CTSCCTSLANPEPRNPEPDNPEP
SCHEMBL4957095 0.94 CTSL (0.58) CTSCCTSLCTSKLTA4HCYP1A2
SCHEMBL6320406 0.89 CTSC (0.63) CTSCCTSLANPEPRNPEPDNPEP
SCHEMBL3497465 0.89 CTSC (0.63) CTSCCTSLANPEPRNPEPDNPEP
SCHEMBL6313096 0.89 ANPEP (0.58) CTSCANPEPRNPEPDNPEPLTA4H
SCHEMBL16468938 0.88 CTSL (0.55) CTSCCTSLCTSKLTA4HCTSS
SCHEMBL28163385 0.88 FOLH1 (0.47) CTSCCTSKCYP1A2CYP3A4CTSH
SCHEMBL1691349 0.87 CTSC (0.76) CTSCCTSKLTA4HCYP1A2CYP3A4
SCHEMBL583121 0.87 CTSC (0.76) CTSCCTSKLTA4HCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021125272-A1 PLANT DISEASE CONTROL AGENT, AND PLANT CULTIVATION METHOD 株式会社カネカ 2021-06-24 WO claimed
US-4107158-A Process for making an octapeptide useful for the treatment of diabetes CHOAY S.A. (FR) 1978-08-15 US claimed
US-4082736-A NOVEL IMMUNOLOGICAL ADJUVANT COMPOUNDS AND METHODS OF PREPARATION THEREOF SYNTEX (U.S.A.) INC. (US) 1978-04-04 US claimed
WO-2021125272-A1 PLANT DISEASE CONTROL AGENT, AND PLANT CULTIVATION METHOD 株式会社カネカ 2021-06-24 WO disclosed
CN-101928329-B Tripeptide boric acid (ester) compound and preparation method and application thereof UNIV BEIJING 2013-07-17 CN disclosed
CN-101928329-A Tripeptide boric acid (ester) compound and preparation method and application thereof UNIV BEIJING 2010-12-29 CN disclosed
WO-2005087251-A1 COMPOSITIONS AND METHODS FOR INHIBITING ABNORMAL CELL GROWTH CLAWNOR, INC. (US) 2005-09-22 WO disclosed
EP-0769967-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC DEVICE COMPRISING SAME AND THEIR USE UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 1997-05-02 EP disclosed
WO-1996005863-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITION AND DIAGNOSTIC DEVICE COMPRISING SAME AND THEIR USE LA REGION WALLONNE (BE) 1996-02-29 WO disclosed
US-5338845-A Analgesics, antiinflammatory agent STERLING WINTHROP INC. (US) 1994-08-16 US disclosed
US-4857650-A Novel renin inhibitory amino acid derivatives KISSEI PHARMACEUTICAL CO., LTD. (JP) 1989-08-15 US disclosed
US-4853463-A Amino acid derivatives KISSEI PHARMACEUTICAL CO., LTD. (JP) 1989-08-01 US disclosed
US-4841067-A RENIN INHIBITORS KISSEI PHARMACEUTICAL CO., LTD. (JP) 1989-06-20 US disclosed
US-4656269-A RENIN INHIBITORY EFFECT WHEN ADMINISTERING ORALLY; HYPOTENSIVE AGENTS KISSEI PHARMACEUTICAL CO., LTD. (JP) 1987-04-07 US disclosed
EP-0216539-A2 Novel amino acid derivatives Kissei Pharmaceutical Co. Ltd. (JP) 1987-04-01 EP disclosed
EP-0206807-A2 Novel amino acid derivatives Kissei Pharmaceutical Co. Ltd. (JP) 1986-12-30 EP disclosed
EP-0190891-A2 Novel amino acid derivatives Kissei Pharmaceutical Co. Ltd. (JP) 1986-08-13 EP disclosed